Mechanisms of spreading proteinopathy in Lewy Body Dementia
路易体痴呆中蛋白质病的传播机制
基本信息
- 批准号:10291694
- 负责人:
- 金额:$ 151.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-15 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AllelesAlpha-Synuclein transgenic mouseAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAmyloid beta-ProteinBiochemicalBiological AssayBrainCell DeathCellsClinicalCollaborationsDataDementiaDementia with Lewy BodiesDiagnosisDiseaseElectron MicroscopyExcisionExhibitsFunctional disorderGastrocnemius MuscleGoalsHindlimbHippocampus (Brain)ImmuneIndividualInjectionsLaboratoriesLewy BodiesLewy Body DementiaLewy Body Variant of Alzheimer&aposs DiseaseLewy body pathologyMAPT geneMeasuresMicrogliaModelingMusMuscleNerve DegenerationNervous system structureNeuraxisNeuronsParkinson&aposs DementiaPathologyPeripheralPhysiologicalPlayProcessProteinsResearchRoleSenile PlaquesSynapsesTestingTissuesToxic effectTransgenic MiceWorkalpha synucleinbeta amyloid pathologyextracellularhuman diseaseimaging approachin vivomouse modelmultiphoton imagingmultiphoton microscopynovel strategiesnovel therapeuticssynucleinopathytau Proteinstau aggregation
项目摘要
PROJECT SUMMARY
One
adequately
alpha-synuclein
diagnosis,
as
pathology
major obstacle to alting neurodegeneration i n Lewy body dementias is a lack of mammalian models that
display the range of neuropathological changes found in the human disease. Although aggregated
Lewy pathology occurring within specific neurons in the cortex i s required to make this
in the vast majority of cases, there is coexistent beta-amyloid plaque pathology in the same regions
Lewy pathology. The relevance these multiple proteinopathies to the formation and spread of Lewy
throughout the nervous system is currently unknown. The
h
Unni lab has been working for many years
to understand the role of cortical alpha-synuclein pathology in synucleinopathies, including pioneering in vivo
multiphoton imaging approaches that can measure the formation and spread of Lewy pathology and the
longitudinal cell fates of individual neurons with and without Lewy inclusions over a period of many months.
Recently, we and our collaborator Randall Woltjer have discovered that the presence of beta-amyloid
pathology greatly increases the formation and/or spread of Lewy pathology in mouse cortex after seeding with
alpha-synuclein preformed fibrils. In this proposal, our team will understand how the presence of beta-amyloid
plaques and tau neurofibrillary tangles accelerate the formation and spread of alpha-synuclein Lewy pathology
throughout the nervous system, and the potentially critical role played by brain-resident immune cells,
microglia, in this process. The results of this work will push forward our ability to understand and develop new
treatments for Lewy body dementias.
项目摘要
一
充分
阿尔法synuclein
诊断,
作为
病理
改变路易体痴呆神经变性的主要障碍是缺乏哺乳动物模型,
显示在人类疾病中发现的神经病理学变化的范围。虽然聚合
路易病理发生在特定的神经元在皮层是必要的,
在绝大多数情况下,在相同区域中存在共存的β-淀粉样斑块病理学,
路易病理学这些多种蛋白质病与路易氏病的形成和扩散的相关性
神经系统中的神经元是目前未知的。的
H
Unni实验室已经工作了很多年
了解皮质α-突触核蛋白病理学在突触核蛋白病中的作用,包括开创性的体内
多光子成像方法,可以测量路易病理的形成和传播,
纵向细胞命运的个别神经元与路易夹杂物和不超过一段时间的许多个月。
最近,我们和我们的合作者Randall Woltjer发现β-淀粉样蛋白的存在
病理学极大地增加了接种后小鼠皮质中Lewy病理学的形成和/或扩散
α-突触核蛋白形成的纤维。在这项提案中,我们的团队将了解β-淀粉样蛋白的存在是如何
斑块和tau神经元缠结加速α-突触核蛋白Lewy病理学的形成和扩散
在整个神经系统中,以及大脑驻留的免疫细胞所扮演的潜在关键角色,
小胶质细胞在这个过程中这项工作的结果将推动我们理解和开发新的
路易体痴呆症的治疗方法
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Vivek Unni其他文献
Vivek Unni的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Vivek Unni', 18)}}的其他基金
Mechanisms of Neurodegeneration in Lewy Body Disorders
路易体疾病的神经变性机制
- 批准号:
9888452 - 财政年份:2017
- 资助金额:
$ 151.22万 - 项目类别:
Mechanisms of Neurodegeneration in Lewy Body Disorders
路易体疾病的神经变性机制
- 批准号:
9362192 - 财政年份:2017
- 资助金额:
$ 151.22万 - 项目类别:
Mechanisms of Neurodegeneration in Lewy Body Disorders
路易体疾病的神经变性机制
- 批准号:
10112964 - 财政年份:2017
- 资助金额:
$ 151.22万 - 项目类别:
Mechanisms of neuronal cell death in synucleinopathies
突触核蛋白病中神经元细胞死亡的机制
- 批准号:
9088666 - 财政年份:2016
- 资助金额:
$ 151.22万 - 项目类别:
Mechanisms of neuronal cell death in synucleinopathies
突触核蛋白病中神经元细胞死亡的机制
- 批准号:
9888446 - 财政年份:2016
- 资助金额:
$ 151.22万 - 项目类别:
The regulation of alpha-synuclein and neurodegeneration in Parkinson's Disease
帕金森病中α-突触核蛋白和神经变性的调节
- 批准号:
8670783 - 财政年份:2010
- 资助金额:
$ 151.22万 - 项目类别:
The regulation of alpha-synuclein and neurodegeneration in Parkinson's Disease
帕金森病中α-突触核蛋白和神经变性的调节
- 批准号:
7868875 - 财政年份:2010
- 资助金额:
$ 151.22万 - 项目类别:
The regulation of alpha-synuclein and neurodegeneration in Parkinson's Disease
帕金森病中α-突触核蛋白和神经变性的调节
- 批准号:
8487465 - 财政年份:2010
- 资助金额:
$ 151.22万 - 项目类别:
The regulation of alpha-synuclein and neurodegeneration in Parkinson's Disease
帕金森病中α-突触核蛋白和神经变性的调节
- 批准号:
8267045 - 财政年份:2010
- 资助金额:
$ 151.22万 - 项目类别:
The regulation of alpha-synuclein and neurodegeneration in Parkinson's Disease
帕金森病中α-突触核蛋白和神经变性的调节
- 批准号:
8054782 - 财政年份:2010
- 资助金额:
$ 151.22万 - 项目类别:
相似海外基金
GI Endotoxin as an Environmental Trigger in an alpha-Synuclein Transgenic Mouse
胃肠道内毒素作为 α-突触核蛋白转基因小鼠的环境触发因素
- 批准号:
8305727 - 财政年份:2010
- 资助金额:
$ 151.22万 - 项目类别:
GI Endotoxin as an Environmental Trigger in an alpha-Synuclein Transgenic Mouse
胃肠道内毒素作为 α-突触核蛋白转基因小鼠的环境触发因素
- 批准号:
8107578 - 财政年份:2010
- 资助金额:
$ 151.22万 - 项目类别:
GI Endotoxin as an Environmental Trigger in an alpha-Synuclein Transgenic Mouse
胃肠道内毒素作为 α-突触核蛋白转基因小鼠的环境触发因素
- 批准号:
7985599 - 财政年份:2010
- 资助金额:
$ 151.22万 - 项目类别:
Effects of repeated low-intensity ultrasound treatment on alpha-synuclein pathology and motor and behavioral outcome in an alpha-synuclein transgenic mouse model
重复低强度超声治疗对 α-突触核蛋白转基因小鼠模型中 α-突触核蛋白病理学以及运动和行为结果的影响
- 批准号:
531992682 - 财政年份:
- 资助金额:
$ 151.22万 - 项目类别:
WBP Fellowship